Compare Avalon Labs (AVL) vs Bio Protocol (BIO) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Avalon Labs vs Bio Protocol — how do they compare? Avalon Labs trades at Rp398.01 (market cap Rp65,03M, Rp99,57M 24h volume), while Bio Protocol trades at Rp495.4 (market cap Rp1,11T, Rp317,28M 24h volume). The key difference: Bio Protocol is far larger — about 17069× Avalon Labs's market cap, and Avalon Labs's circulating supply is 161,7M / 1B AVL (17%) versus 2,2B / 3,3B BIO (68%) for Bio Protocol. Which is the better fit depends on your goals — on Pluang, investors hold Avalon Labs for 8 Days and Bio Protocol for 16 Days on average.
| AVL | BIO | |
|---|---|---|
Market Cap | Rp65,03M | Rp1,11T |
Volume (24h) | Rp99,57M | Rp317,28M |
Circulating Supply | 161,7M / 1B AVL (17%) | 2,2B / 3,3B BIO (68%) |
Typical Hold Time | 8 Days | 16 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AVL trades at Rp392.75 with a bearish technical signal, showing selling pressure in moving averages but neutral oscillators. The token hovers near support at Rp393, with resistance at Rp409. Market cap is Rp66.43M with 17% of max supply circulating. Recent news lacks crypto-specific updates, focusing incorrectly on corporate activities.
Outlook remains cautious due to weak technicals and low liquidity. Key risks include high volatility and limited adoption. Opportunities exist if the project gains ecosystem traction, but current fundamentals show no significant developments for token holders.
Bio Protocol (BIO) trades at Rp503.72 with a market cap of Rp1.12T, showing a bearish technical outlook as indicated by moving averages. The token's circulating supply is 2.2M out of a max 3.3M, with a 68% circulation rate and average hold time of 16 days. Recent news highlights participation in blockchain and tech events, though specific protocol updates are limited. Key support lies at Rp430, with resistance at Rp522.
Overall outlook is cautious due to bearish signals and neutral oscillators. Opportunities include potential rebounds from oversold RSI levels, but risks involve low liquidity and regulatory uncertainties in the crypto space. Investors should monitor network activity and exchange developments closely.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Avalon Labs
Avalon Labs is building an on-chain financial center for Bitcoin, offering solutions like BTC-backed lending, a Bitcoin-backed stablecoin, yield-generating accounts, and a credit card. Our goal is to create a scalable, transparent, and accessible financial network for Bitcoin holders to use Bitcoin as an economic asset. AVL is the governance token of the Avalon Labs ecosystem. We started as the world's largest issuer of Bitcoin-backed collateralized debt positions (CDPs) and have since expanded into DeFi lending, fixed-rate CeDeFi models, and stablecoins. This growth, driven by community demand, positions Avalon as a leader in on-chain finance. With AVL, we empower our community to actively shape the future of Avalon.
Read more on AVL →About Bio Protocol
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →
